SPBC2G2.17c Antibody

What is SPBC2G2.17c and what is its functional significance in fission yeast?

SPBC2G2.17c is a conserved protein in Schizosaccharomyces pombe (fission yeast) that has been implicated in several cellular processes. It appears to be a member of the 'SUN' family proteins involved in aging, oxidative stress response, mitochondrial biogenesis, DNA replication, and cell wall morphology . Quantitative analysis shows variable expression levels in proliferating versus quiescent cells .

The protein has been identified as a cell wall component in fission yeast, with potential roles in stress response mechanisms . SPBC2G2.17c shows differential expression under specific conditions, including nitrogen starvation and oxidative stress. When studying this protein, researchers should consider its context-dependent expression, particularly in response to environmental stressors like cisplatin treatment .

How are antibodies against SPBC2G2.17c typically generated for research applications?

Generation of antibodies against SPBC2G2.17c typically follows established protocols for yeast proteins:

Recombinant Protein Expression Method:

• Clone the SPBC2G2.17c coding region into an expression vector with a purification tag (commonly His-tag)

• Express the recombinant protein in E. coli as demonstrated in similar fission yeast protein studies

• Purify the tagged protein using affinity chromatography

• Use the purified protein to immunize animals (typically rabbits for polyclonal or mice for monoclonal antibodies)

Synthetic Peptide Approach:
For targeted epitope recognition, researchers can use synthetic peptides corresponding to unique regions of SPBC2G2.17c, conjugated to carrier proteins like KLH.

Quality validation should include Western blot analysis comparing wild-type expression with SPBC2G2.17c deletion strains, similar to validation procedures used for other fission yeast proteins .

What expression patterns and localization of SPBC2G2.17c should researchers be aware of when using its antibodies?

Expression of SPBC2G2.17c varies significantly based on cellular conditions:

This differential expression pattern suggests SPBC2G2.17c plays a more significant role during cellular quiescence. When designing immunostaining experiments, researchers should consider:

• The protein shows increased abundance during quiescence, making detection potentially easier in this state

• Subcellular localization may change depending on growth conditions or stress responses

• Expression can be induced under certain stress conditions, particularly following cisplatin treatment

• The protein may associate with cell wall components based on mass spectrometric identification of covalently bound cell wall proteins

Researchers should optimize fixation and permeabilization protocols specifically for the cellular state being investigated.

How can SPBC2G2.17c antibodies be validated for specificity in immunological studies?

Rigorous validation is essential for experiments involving SPBC2G2.17c antibodies:

Recommended Validation Protocol:

• Genetic controls: Compare antibody reactivity between wild-type and ΔSPBC2G2.17c deletion strains in Western blots and immunofluorescence

• Overexpression analysis: Test if band intensity increases upon overexpression of SPBC2G2.17c, as demonstrated for other fission yeast proteins

• Depletion approach: Pre-incubate the antibody with recombinant SPBC2G2.17c protein and confirm signal depletion

• Cross-reactivity assessment: Examine potential cross-reactivity with homologous proteins, particularly other SUN family members

• Peptide competition: Use the immunizing peptide (if applicable) to block antibody binding

A comprehensive validation example from the literature involves the Rhb1 antibody in fission yeast where antibody specificity was confirmed by showing that "incubation with the Rhb1 beads clearly abolished the 20.5-kDa band, whereas after incubation with beads alone, the antibody could still recognize the 20.5-kDa band" .

What methodological considerations exist for using SPBC2G2.17c antibodies in chromatin studies?

When using SPBC2G2.17c antibodies for chromatin immunoprecipitation (ChIP) or related studies:

• Fixation optimization: Test various crosslinking times (1-20 minutes) with formaldehyde to find the optimal balance between chromatin preservation and epitope accessibility

• Sonication parameters: Optimize sonication conditions to generate 200-500 bp fragments for efficient immunoprecipitation

• Antibody concentration: Titrate antibody amounts (typically 2-10 μg per ChIP reaction) to maximize signal-to-noise ratio

• Controls: Include:

  • Input chromatin (pre-immunoprecipitation sample)

  • No-antibody control

  • Unrelated antibody control (e.g., IgG)

  • Chromatin from ΔSPBC2G2.17c strain

The antibody should be validated for ChIP applications specifically, as some antibodies that work well for Western blotting may not function effectively in ChIP. Consider validating through ChIP-qPCR targeting regions where SPBC2G2.17c is expected to bind based on its functional characteristics .

How might post-translational modifications affect SPBC2G2.17c antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of SPBC2G2.17c:

• Phosphorylation: As SPBC2G2.17c may be involved in stress responses, it could undergo phosphorylation in response to stress signals, potentially altering epitope accessibility

• Glycosylation: Given its association with cell wall components, SPBC2G2.17c may be glycosylated, which can mask epitopes and reduce antibody binding

• Ubiquitination: Stress-related proteins often undergo ubiquitination, which can sterically hinder antibody access

Methodological Recommendations:

• Generate multiple antibodies targeting different regions of the protein

• Consider developing modification-specific antibodies if particular PTMs are of research interest

• When studying PTMs, use phosphatase or glycosidase treatments as controls to confirm specificity

• For detecting ubiquitinated forms, consider denaturing conditions prior to immunoprecipitation

Researchers studying stress responses should be particularly attentive to potential modifications, as cellular stress (including cisplatin treatment) has been shown to alter SPBC2G2.17c expression patterns .

What are the optimal protocols for immunoprecipitation of SPBC2G2.17c?

Based on successful immunoprecipitation protocols for other fission yeast proteins:

Recommended IP Protocol:

• Cell lysis: Lyse cells in extraction buffer (25 mM HEPES-KOH pH 7.5, 200 mM NaCl, 10% glycerol, 0.1% NP-40, 1 mM phenylmethylsulfonyl fluoride) supplemented with protease inhibitor cocktail

• Clarification: Centrifuge extracts twice (20 min at 7600 rpm and 30 min at 20,000 rpm)

• Pre-clearing: Incubate lysates with Protein A/G beads to remove non-specific binding proteins

• Immunoprecipitation: Incubate pre-cleared lysates with anti-SPBC2G2.17c antibody (typically 2-5 μg) overnight at 4°C

• Bead capture: Add Protein A/G beads for 2-3 hours at 4°C

• Washing: Wash beads 4-5 times with extraction buffer

• Elution: Elute bound proteins with SDS sample buffer or specific elution buffer depending on downstream applications

For confirmation of results, include appropriate controls:

• Input sample (10% of pre-IP lysate)

• Negative control using non-specific IgG

• When possible, ΔSPBC2G2.17c strain as a biological negative control

For studying protein-protein interactions, consider crosslinking prior to lysis or using techniques like BioID or proximity labeling .

How should researchers troubleshoot weak or nonspecific signals when using SPBC2G2.17c antibodies in Western blotting?

When facing challenges with SPBC2G2.17c antibody performance in Western blotting:

Troubleshooting Weak Signals:

• Sample preparation: Ensure complete lysis; consider using stronger detergents or denaturing conditions

• Loading quantity: Increase the amount of protein loaded (especially if SPBC2G2.17c is low-abundance)

• Transfer efficiency: Optimize transfer conditions; consider semi-dry versus wet transfer based on protein size

• Blocking optimization: Test different blocking agents (milk versus BSA) as some may mask the epitope

• Antibody concentration: Titrate primary antibody concentration (typically 0.5-5 μg/ml)

• Incubation conditions: Extend primary antibody incubation (overnight at 4°C)

• Detection system: Use more sensitive detection methods (ECL Plus or fluorescent-based detection)

Addressing Nonspecific Signals:

• Antibody specificity: Re-test antibody validation using knockout controls

• Blocking stringency: Increase blocking time or detergent concentration in washing buffers

• Pre-adsorption: Pre-incubate antibody with extracts from ΔSPBC2G2.17c strain

• Titration: Reduce antibody concentration to minimize background

• Cross-reactivity assessment: Check for homologous proteins in S. pombe that might be recognized

When analyzing SPBC2G2.17c, note that its expression increases substantially in quiescent cells (3.6 molecules/cell) compared to proliferating cells (0.52 molecules/cell) , which may require different detection strategies.

What considerations are important when using SPBC2G2.17c antibodies for immunofluorescence microscopy?

For optimal immunofluorescence results with SPBC2G2.17c antibodies:

Fixation and Permeabilization Options:

• Paraformaldehyde fixation: 4% PFA for 10-15 minutes at room temperature

• Methanol fixation: 100% methanol at -20°C for 6 minutes (may better preserve certain epitopes)

• Permeabilization: 0.1% Triton X-100 for 5 minutes or 0.01% digitonin for gentler permeabilization

Key Protocol Considerations:

• Cell wall digestion: For optimal antibody penetration, treat cells with zymolyase (0.5-1 mg/ml for 10-30 minutes)

• Epitope retrieval: Consider heat-induced epitope retrieval methods if the epitope is masked

• Blocking: Block with 5% BSA or 5% normal serum from the secondary antibody species

• Antibody dilution: Start with 1:100-1:500 dilution and optimize

• Controls: Include:

  • Secondary antibody only

  • ΔSPBC2G2.17c strain

  • Competing peptide (if available)

• Imaging parameters: Use deconvolution technology to reduce noise, as demonstrated for other fission yeast proteins

For specific localization studies, researchers should consider synchronizing cells or inducing stress conditions to observe condition-dependent changes in SPBC2G2.17c localization and abundance.

How can SPBC2G2.17c antibodies be utilized in studying protein dynamics during cellular stress responses?

SPBC2G2.17c appears to be involved in stress responses, making antibodies valuable tools for studying its dynamics:

Experimental Approaches:

• Time-course analysis: Monitor SPBC2G2.17c levels at different time points following stress induction (oxidative stress, nutrient starvation, cisplatin treatment)

• Subcellular fractionation: Combine with Western blotting to track changes in protein localization during stress responses

• Co-immunoprecipitation: Identify stress-dependent interaction partners using:

  • Crosslinking approaches

  • Tandem affinity purification with mass spectrometry

  • Proximity labeling methods

Study Design Recommendations:

• Include both acute and chronic stress conditions

• Compare proliferating versus quiescent cells (given the significant expression difference)

• Use complementary tagged versions (e.g., GFP-tagged SPBC2G2.17c) to validate antibody-based observations

• Consider combining with transcriptome analysis to correlate protein dynamics with gene expression changes

For nitrogen starvation experiments, follow established protocols: "cells were exponentially grown in EMM2 to a density of 2 x 106 cells/mL at 26°C, harvested by vacuum filtration using a nitrocellulose membrane (0.45 μm pore size), washed in EMM2-N (EMM2 lacking NH4Cl) once on the membrane, and then re-suspended in EMM2-N" .

What strategies should be employed when developing new antibodies against specific epitopes of SPBC2G2.17c?

When developing epitope-specific antibodies against SPBC2G2.17c:

Epitope Selection Criteria:

• Sequence uniqueness: Choose regions with minimal homology to other S. pombe proteins

• Surface accessibility: Focus on hydrophilic, surface-exposed regions

• Secondary structure: Avoid regions with complex secondary structures when possible

• Evolutionary conservation: Consider conservation if the antibody needs to recognize homologs in other species

• Post-translational modifications: Avoid regions likely to be modified unless specifically targeting modified epitopes

Production Strategies:

• Synthetic peptide approach:

  • Select 12-20 amino acid sequences

  • Add a terminal cysteine for conjugation if none present

  • Conjugate to carrier protein (KLH or BSA)

  • Immunize rabbits for polyclonal or mice for monoclonal production

• Recombinant fragment approach:

  • Express domains of SPBC2G2.17c (50-150 amino acids)

  • Ensure proper folding through solubility screening

  • Purify using affinity tags prior to immunization

• Single-domain antibody alternatives:

  • Consider nanobody development using synthetic libraries as described for other proteins

  • These can be particularly useful for detecting specific conformational states

For validation, implement comprehensive testing across multiple applications (Western blot, IP, IF) using both overexpression and knockout controls.

How can researchers integrate SPBC2G2.17c antibody data with genomic and transcriptomic analyses?

For comprehensive understanding of SPBC2G2.17c function:

Integrated Analysis Approaches:

• ChIP-seq integration:

  • Compare SPBC2G2.17c binding sites with transcriptomic changes under similar conditions

  • Correlate with histone modification data to understand chromatin context

• Proteomics correlation:

  • Align protein abundance (determined by antibody-based quantification) with transcriptomic data

  • Identify post-transcriptional regulation by comparing mRNA and protein levels

• Multi-omics visualization:

  • Use tools like Cytoscape or R packages to visualize relationships between:

    • Protein-protein interactions (from co-IP studies)

    • Expression changes (from transcriptomics)

    • Binding profiles (from ChIP data)

• Functional validation:

  • For genes identified in screens, use SPBC2G2.17c antibodies to confirm protein-level changes

  • Integrate with phenotypic data from genetic screens

Analytical Considerations:

• Account for the significant expression difference between proliferating (0.52 molecules/cell) and quiescent states (3.6 molecules/cell)

• Consider time-resolved analyses to capture dynamic changes during stress responses

• Validate key findings with orthogonal methods to confirm antibody specificity